Halder Venture Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 15, 2025, 11:27 am

Quick Insight

Halder Venture Ltd, operating in the commodities trading industry focusing on rice, demonstrates a solid financial standing with a share price of 224 and a market capitalization of 186 Cr. The company's P/E ratio stands at 9.45, indicating potential undervaluation, while ROE and ROCE at 14.8% and 16.2% respectively reflect efficient capital utilization. With a low OPM of 6.10%, the company may need to focus on improving operational efficiency. The healthy promoter holding of 73.84% provides stability, though the relatively high borrowings of 298 Cr raise leverage concerns. Shareholders' diversity with 1,588 individuals holding stakes adds resilience. Overall, Halder Venture Ltd presents a mixed picture with room for operational enhancement and debt management.

Competitors of Halder Venture Ltd

All Competitor Stocks of Halder Venture Ltd

Quarterly Result

Last Updated: August 19, 2025, 2:10 pm

Below is a detailed analysis of the quarterly data for Halder Venture Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 103.21 Cr.. The value appears to be declining and may need further review. It has decreased from 146.99 Cr. (Mar 2025) to 103.21 Cr., marking a decrease of 43.78 Cr..
• For Expenses, as of Jun 2025, the value is 96.91 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 146.74 Cr. (Mar 2025) to 96.91 Cr., marking a decrease of 49.83 Cr..
• For Operating Profit, as of Jun 2025, the value is 6.30 Cr.. The value appears strong and on an upward trend. It has increased from 0.25 Cr. (Mar 2025) to 6.30 Cr., marking an increase of 6.05 Cr..
• For OPM %, as of Jun 2025, the value is 6.10%. The value appears strong and on an upward trend. It has increased from 0.17% (Mar 2025) to 6.10%, marking an increase of 5.93%.
• For Other Income, as of Jun 2025, the value is 9.11 Cr.. The value appears to be declining and may need further review. It has decreased from 11.46 Cr. (Mar 2025) to 9.11 Cr., marking a decrease of 2.35 Cr..
• For Interest, as of Jun 2025, the value is 8.22 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.37 Cr. (Mar 2025) to 8.22 Cr., marking a decrease of 1.15 Cr..
• For Depreciation, as of Jun 2025, the value is 1.21 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.31 Cr. (Mar 2025) to 1.21 Cr., marking a decrease of 0.10 Cr..
• For Profit before tax, as of Jun 2025, the value is 5.98 Cr.. The value appears strong and on an upward trend. It has increased from 1.03 Cr. (Mar 2025) to 5.98 Cr., marking an increase of 4.95 Cr..
• For Tax %, as of Jun 2025, the value is 52.34%. The value appears to be improving (decreasing) as expected. It has decreased from 917.48% (Mar 2025) to 52.34%, marking a decrease of 865.14%.
• For Net Profit, as of Jun 2025, the value is 2.86 Cr.. The value appears strong and on an upward trend. It has increased from -8.41 Cr. (Mar 2025) to 2.86 Cr., marking an increase of 11.27 Cr..
• For EPS in Rs, as of Jun 2025, the value is 6.83. The value appears strong and on an upward trend. It has increased from -20.28 (Mar 2025) to 6.83, marking an increase of 27.11.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: September 15, 2025, 3:09 am

Balance Sheet

Last Updated: September 10, 2025, 3:49 pm

Below is a detailed analysis of the balance sheet data for Halder Venture Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2024) to 4.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 149.00 Cr.. The value appears strong and on an upward trend. It has increased from 131.00 Cr. (Mar 2024) to 149.00 Cr., marking an increase of 18.00 Cr..
• For Borrowings, as of Mar 2025, the value is 298.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 238.00 Cr. (Mar 2024) to 298.00 Cr., marking an increase of 60.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 141.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 71.00 Cr. (Mar 2024) to 141.00 Cr., marking an increase of 70.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 592.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 444.00 Cr. (Mar 2024) to 592.00 Cr., marking an increase of 148.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 47.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49.00 Cr. (Mar 2024) to 47.00 Cr., marking a decrease of 2.00 Cr..
• For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 542.00 Cr.. The value appears strong and on an upward trend. It has increased from 393.00 Cr. (Mar 2024) to 542.00 Cr., marking an increase of 149.00 Cr..
• For Total Assets, as of Mar 2025, the value is 592.00 Cr.. The value appears strong and on an upward trend. It has increased from 444.00 Cr. (Mar 2024) to 592.00 Cr., marking an increase of 148.00 Cr..

However, the Borrowings (298.00 Cr.) are higher than the Reserves (149.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Halder Venture Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 62.81. This value is within the healthy range. It has increased from 36.91 (Mar 24) to 62.81, marking an increase of 25.90.
• For Diluted EPS (Rs.), as of Mar 25, the value is 62.81. This value is within the healthy range. It has increased from 36.91 (Mar 24) to 62.81, marking an increase of 25.90.
• For Cash EPS (Rs.), as of Mar 25, the value is 67.56. This value is within the healthy range. It has increased from 52.64 (Mar 24) to 67.56, marking an increase of 14.92.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 396.08. It has decreased from 431.23 (Mar 24) to 396.08, marking a decrease of 35.15.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 396.08. It has decreased from 431.23 (Mar 24) to 396.08, marking a decrease of 35.15.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,184.46. It has increased from 2,036.44 (Mar 24) to 2,184.46, marking an increase of 148.02.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 183.65. This value is within the healthy range. It has increased from 129.87 (Mar 24) to 183.65, marking an increase of 53.78.
• For PBIT / Share (Rs.), as of Mar 25, the value is 170.68. This value is within the healthy range. It has increased from 114.14 (Mar 24) to 170.68, marking an increase of 56.54.
• For PBT / Share (Rs.), as of Mar 25, the value is 102.03. This value is within the healthy range. It has increased from 54.52 (Mar 24) to 102.03, marking an increase of 47.51.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 54.60. This value is within the healthy range. It has increased from 36.91 (Mar 24) to 54.60, marking an increase of 17.69.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 54.48. This value is within the healthy range. It has increased from 36.91 (Mar 24) to 54.48, marking an increase of 17.57.
• For PBDIT Margin (%), as of Mar 25, the value is 8.40. This value is below the healthy minimum of 10. It has increased from 6.37 (Mar 24) to 8.40, marking an increase of 2.03.
• For PBIT Margin (%), as of Mar 25, the value is 7.81. This value is below the healthy minimum of 10. It has increased from 5.60 (Mar 24) to 7.81, marking an increase of 2.21.
• For PBT Margin (%), as of Mar 25, the value is 4.67. This value is below the healthy minimum of 10. It has increased from 2.67 (Mar 24) to 4.67, marking an increase of 2.00.
• For Net Profit Margin (%), as of Mar 25, the value is 2.49. This value is below the healthy minimum of 5. It has increased from 1.81 (Mar 24) to 2.49, marking an increase of 0.68.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.49. This value is below the healthy minimum of 8. It has increased from 1.81 (Mar 24) to 2.49, marking an increase of 0.68.
• For Return on Networth / Equity (%), as of Mar 25, the value is 13.75. This value is below the healthy minimum of 15. It has decreased from 19.66 (Mar 24) to 13.75, marking a decrease of 5.91.
• For Return on Capital Employeed (%), as of Mar 25, the value is 33.47. This value is within the healthy range. It has increased from 24.08 (Mar 24) to 33.47, marking an increase of 9.39.
• For Return On Assets (%), as of Mar 25, the value is 3.55. This value is below the healthy minimum of 5. It has increased from 2.62 (Mar 24) to 3.55, marking an increase of 0.93.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has increased from 0.18 (Mar 24) to 0.22, marking an increase of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.94. This value exceeds the healthy maximum of 1. It has decreased from 4.01 (Mar 24) to 1.94, marking a decrease of 2.07.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.63. It has increased from 1.61 (Mar 24) to 1.63, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 1.17. This value is below the healthy minimum of 1.5. It has decreased from 1.26 (Mar 24) to 1.17, marking a decrease of 0.09.
• For Quick Ratio (X), as of Mar 25, the value is 0.47. This value is below the healthy minimum of 1. It has decreased from 0.73 (Mar 24) to 0.47, marking a decrease of 0.26.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.92. This value is below the healthy minimum of 4. It has increased from 2.46 (Mar 24) to 3.92, marking an increase of 1.46.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 1.50. This value is below the healthy minimum of 20. It has decreased from 2.70 (Mar 24) to 1.50, marking a decrease of 1.20.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 1.21. This value is below the healthy minimum of 20. It has decreased from 1.89 (Mar 24) to 1.21, marking a decrease of 0.68.
• For Earning Retention Ratio (%), as of Mar 25, the value is 98.50. This value exceeds the healthy maximum of 70. It has increased from 97.30 (Mar 24) to 98.50, marking an increase of 1.20.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 98.79. This value exceeds the healthy maximum of 70. It has increased from 98.11 (Mar 24) to 98.79, marking an increase of 0.68.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.71. This value is below the healthy minimum of 3. It has increased from 2.18 (Mar 24) to 2.71, marking an increase of 0.53.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.82. This value is below the healthy minimum of 3. It has increased from 1.62 (Mar 24) to 1.82, marking an increase of 0.20.
• For Enterprise Value (Cr.), as of Mar 25, the value is 537.14. It has increased from 392.19 (Mar 24) to 537.14, marking an increase of 144.95.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 1. It has increased from 0.60 (Mar 24) to 0.63, marking an increase of 0.03.
• For EV / EBITDA (X), as of Mar 25, the value is 7.57. This value is within the healthy range. It has decreased from 9.55 (Mar 24) to 7.57, marking a decrease of 1.98.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 1. It has increased from 0.13 (Mar 24) to 0.29, marking an increase of 0.16.
• For Retention Ratios (%), as of Mar 25, the value is 98.49. This value exceeds the healthy maximum of 70. It has increased from 97.29 (Mar 24) to 98.49, marking an increase of 1.20.
• For Price / BV (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has increased from 1.45 (Mar 24) to 1.63, marking an increase of 0.18.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 1. It has increased from 0.13 (Mar 24) to 0.29, marking an increase of 0.16.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has decreased from 0.13 (Mar 24) to 0.08, marking a decrease of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness